Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 7, 2013; 19(33): 5575-5580
Published online Sep 7, 2013. doi: 10.3748/wjg.v19.i33.5575
Published online Sep 7, 2013. doi: 10.3748/wjg.v19.i33.5575
Figure 1 Progression of serum hepatitis B virus DNA and aminotransferase.
Telbivudine was introduced when alanine aminotransferase (ALT) and hepatitis B virus (HBV) DNA level was both high. The indication was clear and sufficient, and lactic acidosis happened after 11 mo of antiviral treatment when liver function was controlled well. HBV DNA continued to be normal after telbivudine was stopped and changed to tenofovir soon after.
- Citation: Jin JL, Hu P, Lu JH, Luo SS, Huang XY, Weng XH, Zhang JM. Lactic acidosis during telbivudine treatment for HBV: A case report and literature review. World J Gastroenterol 2013; 19(33): 5575-5580
- URL: https://www.wjgnet.com/1007-9327/full/v19/i33/5575.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i33.5575